GPT and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, the CML+CIGB-258 group showed AST and ALT levels of 353 and 175 IU/L, respectively, which were 32% and 31% lower than those of the CML+PBS group, respectively.